HuGE Literature Finder
Records 1-26
|
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology 2020 Apr . Shim J H, Kim H S, Cha H, Kim S, Kim T M, Anagnostou V, Choi Y-L, Jung H A, Sun J-M, Ahn J S, Ahn M-J, Park K, Park W-Y, Lee S |
|
HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
The Journal of rheumatology 2017 Sep 44 (9): 1389-1393. Chen Zhiyong, Wang Yan, Kuwana Masataka, Xu Xue, Hu Wei, Feng Xuebing, Wang Hong, Kimura Akinori, Sun Lingy |
|
The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Archivum immunologiae et therapiae experimentalis 2017 Jan . Kandilarova Snezhina Mihailova, Paschen Annette, Mihaylova Anastassia, Ivanova Milena, Schadendorf Dirk, Naumova Elissave |
|
Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population.
HLA 2017 12 90 (6): 354-359. Lin J M, Zhang Y B, Peng Q L, Yang H B, Shi J L, Gu M L, Zhao W M, Wang G |
|
Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.
PloS one 2017 12 (1): e0169032. Poras Isabelle, Yaghi Layale, Martelli-Palomino Gustavo, Mendes-Junior Celso T, Muniz Yara Costa Netto, Cagnin Natalia F, Sgorla de Almeida Bibiana, Castelli Erick C, Carosella Edgardo D, Donadi Eduardo A, Moreau Philip |
|
Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms.
Pharmacogenomics 2016 Apr 17 (5): 459-62. Kulkarni Diptee, Song Kijoung, Briley Linda, King Karen, Dabrowski Christine, Mookerjee Bijoyesh, Legos Jeff, Spraggs Col |
|
A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity.
Human molecular genetics 2015 May 24 (9): 2681-8. Chen Dan, Gaborieau Valérie, Zhao Yao, Chabrier Amélie, Wang Huibo, Waterboer Tim, Zaridze David, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Bencko Vladimir, Janout Vladimir, Foretova Lenka, Mates Ioan Nicolae, Szeszenia-Dabrowska Neonila, Boffetta Paolo, Pawlita Michael, Lathrop Mark, Gyllensten Ulf, Brennan Paul, McKay James |
|
Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.
Oncotarget 2015 Jan 6 (2): 1115-27. Wong Stephen Q, Behren Andreas, Mar Victoria J, Woods Katherine, Li Jason, Martin Claire, Sheppard Karen E, Wolfe Rory, Kelly John, Cebon Jonathan, Dobrovic Alexander, McArthur Grant |
|
MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.
Disease markers 2015 2015 831864. Campillo José Antonio, López-Hernández Ruth, Martínez-Banaclocha Helios, Bolarín José Miguel, Gimeno Lourdes, Mrowiec Anna, López Manuela, Las Heras Beatriz, Minguela Alfredo, Moya-Quiles Maria Rosa, Legáz Isabel, Frías-Iniesta José Francisco, García-Alonso Ana María, Álvarez-López María Rocío, Martínez-Escribano Jorge Antonio, Muro Manu |
|
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients.
PloS one 2015 10 (7): e0132745. Tarhini Ahmad A, Lin Yan, Zahoor Haris, Shuai Yongli, Butterfield Lisa H, Ringquist Steven, Gogas Helen, Sander Cindy, Lee Sandra, Agarwala Sanjiv S, Kirwood John |
|
Genetic basis for clinical response to CTLA-4 blockade in melanoma.
The New England journal of medicine 2014 Dec 371 (23): 2189-99. Snyder Alexandra, Makarov Vladimir, Merghoub Taha, Yuan Jianda, Zaretsky Jesse M, Desrichard Alexis, Walsh Logan A, Postow Michael A, Wong Phillip, Ho Teresa S, Hollmann Travis J, Bruggeman Cameron, Kannan Kasthuri, Li Yanyun, Elipenahli Ceyhan, Liu Cailian, Harbison Christopher T, Wang Lisu, Ribas Antoni, Wolchok Jedd D, Chan Timothy |
|
HLA-C -35kb expression SNP is associated with differential control of ß-HPV infection in squamous cell carcinoma cases and controls.
PloS one 2014 9 (8): e103710. Vineretsky Karin A, Karagas Margaret R, Kuriger-Laber Jacquelyn K, Waterboer Tim, Pawlita Michael, Nelson Heather |
|
KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.
Immunogenetics 2013 Jan . Campillo JA, Legaz I, López-Álvarez MR, Bolarín JM, Las Heras B, Muro M, Minguela A, Moya-Quiles MR, Blanco-García R, Martínez-Banaclocha H, García-Alonso AM, Alvarez-López MR, Martínez-Escribano JA |
|
Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
International journal of dermatology 2012 Dec 51 (12): 1448-53. de Carvalho André V E, Bonamigo Renan R, da Silva Cristina M, Pinto Angela C De Zor |
|
Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population.
Arthritis and rheumatism 2012 Nov 64 (11): 3736-40. Gono Takahisa, Kawaguchi Yasushi, Kuwana Masataka, Sugiura Tomoko, Furuya Takefumi, Takagi Kae, Ichida Hisae, Katsumata Yasuhiro, Hanaoka Masanori, Ota Yuko, Yamanaka Hisas |
|
Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.
Cancer 2010 Sep 116 (18): 4326-33. Gogas Helen, Kirkwood John M, Falk Christine S, Dafni Urania, Sondak Vernon K, Tsoutsos Dimosthenis, Stratigos Alexandros, Markopoulos Christos, Pectasides Dimitrios, Spyropoulou-Vlachou Mar |
|
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
Cancer immunology, immunotherapy : CII 2009 Oct 58 (10): 1599-608. Helgadottir Hildur, Andersson Emilia, Villabona Lisa, Kanter Lena, van der Zanden Henk, Haasnoot Geert W, Seliger Barbara, Bergfeldt Kjell, Hansson Johan, Ragnarsson-Olding Boel, Kiessling Rolf, Masucci Giuseppe Valenti |
|
HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
The British journal of dermatology 2006 Feb 154 (2): 261-6. Planelles D, Nagore E, Moret A, Botella-Estrada R, Vila E, Guillén C, Montoro J |
|
HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.
Immunogenetics 2006 Jan 57 (12): 926-33. Campillo José A, Martínez-Escribano Jorge A, Muro Manuel, Moya-Quiles Rosa, Marín Luis A, Montes-Ares Olga, Guerra Natalia, Sánchez-Pedreño Paloma, Frías José F, Lozano José A, García-Alonso Ana M, Alvarez-López M Roc |
|
HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Investigative ophthalmology & visual science 2006 Jan 47 (1): 3-6. Maat Willem, Haasnoot Geert W, Claas Frans H J, Schalij-Delfos Nicoline E, Schreuder Geziena M T, Jager Martine |
|
Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Cancer immunology, immunotherapy : CII 2005 Feb 54 (2): 172-8. Naumova Elissaveta, Mihaylova Anastassia, Stoitchkov Konstantin, Ivanova Milena, Quin Ludmila, Toneva Migle |
|
Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
Molecular vision 2005 11 (): 1166-72. Metzelaar-Blok J A W, Hurks H M H, Naipal A, De Lange P, Keunen J E E, Claas F H J, Doxiadis I I N, Jager M |
|
HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
Tissue antigens 2004 Jul 64 (1): 84-7. Luongo V, Pirozzi G, Caracò C, Errico S, de Angelis F, Celentano E, Paino F, Chiofalo M G, Luongo M, Mozzillo N, Lombardi M |
|
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.
Annals of surgical oncology 2002 Jul 9 (6): 587-93. Lee Jeffrey E, Abdalla Joseph, Porter Geoffrey A, Bradford Loretta, Grimm Elizabeth A, Reveille John D, Mansfield Paul F, Gershenwald Jeffrey E, Ross Merrick |
|
Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2002 Feb 29 (1): 17-23. Howell W M, Turner S J, Collins A, Bateman A C, Theaker J |
|
Molecular genetic analysis of HLA-DR and -DQ alleles in Spanish patients with melanoma.
Acta dermato-venereologica 2002 82 (2): 90-3. Nagore E, Planelles M D, Ledesma E, Millán J M, Insa A, Oliver V, Guillén C, Fortea J |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 22, 2021
- Content source: